Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1980 2
1981 2
1982 3
1983 3
1984 2
1985 7
1986 3
1987 1
1988 1
1989 1
1990 2
1991 2
1992 5
1993 4
1994 2
1995 1
1996 2
1997 4
1998 2
2000 2
2001 4
2002 4
2003 2
2004 2
2005 3
2006 1
2007 5
2008 1
2009 2
2011 1
2013 1
2015 2
2016 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Results by year

Filters applied: . Clear all
Page 1
International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial.
International Collaboration of Trialists; Medical Research Council Advanced Bladder Cancer Working Party (now the National Cancer Research Institute Bladder Cancer Clinical Studies Group); European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group; Australian Bladder Cancer Study Group; National Cancer Institute of Canada Clinical Trials Group; Finnbladder; Norwegian Bladder Cancer Study Group; Club Urologico Espanol de Tratamiento Oncologico Group; Griffiths G, Hall R, Sylvester R, Raghavan D, Parmar MK. International Collaboration of Trialists, et al. J Clin Oncol. 2011 Jun 1;29(16):2171-7. doi: 10.1200/JCO.2010.32.3139. Epub 2011 Apr 18. J Clin Oncol. 2011. PMID: 21502557 Free PMC article. Clinical Trial.
Aggressive superficial bladder cancer.
Harland SJ. Harland SJ. Eur J Cancer. 1994;30A(7):899-900. doi: 10.1016/0959-8049(94)90108-2. Eur J Cancer. 1994. PMID: 7946577 No abstract available.
The pT1 G3 bladder tumour.
Birch BR, Harland SJ. Birch BR, et al. Among authors: harland sj. Br J Urol. 1989 Aug;64(2):109-16. doi: 10.1111/j.1464-410x.1989.tb05967.x. Br J Urol. 1989. PMID: 2670044 Review. No abstract available.
A second look at the pT1 G3 bladder tumour.
Harland SJ. Harland SJ. Clin Oncol (R Coll Radiol). 2005 Oct;17(7):498-502. doi: 10.1016/j.clon.2005.07.005. Clin Oncol (R Coll Radiol). 2005. PMID: 16238136 Review.
Polymorphic acetylation of hydralazine.
Timbrell JA, Harland SJ, Facchini V. Timbrell JA, et al. Among authors: harland sj. Clin Pharmacol Ther. 1980 Sep;28(3):350-5. doi: 10.1038/clpt.1980.173. Clin Pharmacol Ther. 1980. PMID: 7408395
Multiple loci on 8q24 associated with prostate cancer susceptibility.
Al Olama AA, Kote-Jarai Z, Giles GG, Guy M, Morrison J, Severi G, Leongamornlert DA, Tymrakiewicz M, Jhavar S, Saunders E, Hopper JL, Southey MC, Muir KR, English DR, Dearnaley DP, Ardern-Jones AT, Hall AL, O'Brien LT, Wilkinson RA, Sawyer E, Lophatananon A; UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology; UK Prostate testing for cancer and Treatment study (ProtecT Study) Collaborators; Horwich A, Huddart RA, Khoo VS, Parker CC, Woodhouse CJ, Thompson A, Christmas T, Ogden C, Cooper C, Donovan JL, Hamdy FC, Neal DE, Eeles RA, Easton DF. Al Olama AA, et al. Nat Genet. 2009 Oct;41(10):1058-60. doi: 10.1038/ng.452. Epub 2009 Sep 20. Nat Genet. 2009. PMID: 19767752
81 results